Investigation of Structure-Activity Relationship Between Chemical Structure and CCR5 Anti HIV-1 Activity in a Class of 1-[N-(Methyl)-N- (Phenylsulfonyl) Amino]-2-(Phenyl)-4-[4-(Substituted)Piperidin-1-yl]Butane Derivatives: The Electronic-Topological Approach

被引:3
作者
Saracoglu, Murat [1 ]
Kandemirli, Sedat Giray [2 ]
Basaran, Murat Alper [3 ]
Sayiner, Hakan [4 ]
Kandemirli, Fatma [3 ]
机构
[1] Erciyes Univ, Fac Educ, TR-38039 Kayseri, Turkey
[2] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey
[3] Nigde Univ, Fac Arts & Sci, TR-51240 Nigde, Turkey
[4] Adiyaman Kahta State Hosp, TR-02400 Kahta, Adiyaman, Turkey
关键词
Electron-topological method; HIV-1; piperidin derivatives; structure-activity relationships; ANTI-HIV-1; AGENTS; RECEPTOR; ANTAGONISTS; SERIES; INTEGRASE;
D O I
10.2174/157016211797635964
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relationship between chemical structure and CCR5 anti HIV-1 activity was investigated in the series of 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted) piperidin-1-yl]butanes derivatives including 114 molecules by using the Electron-Topological Method (ETM). In the frameworks of this approach, its input data were taken as the results of conformational and quantum-mechanical calculations. Conformational analysis and quantum-chemical calculations were carried out for each molecule. Then molecular fragments being specific for active molecules and non-active molecules were revealed by using ETM. The result of testing showed the high ability of ETM in predicting the activity and inactivity investigated series. In order to classify and to develop a model for those molecules, cluster and discriminant analyses are conducted. First, cluster analysis is implemented in order to classify similar molecules into the groups. Then, discriminant analysis is used to construct models including descriptors. By doing so, two obtained discriminant functions segregate those molecules into three different groups by using the descriptors called E-HOMO, Dipole Moment and SEZPE.
引用
收藏
页码:300 / 312
页数:13
相关论文
共 24 条
[1]  
[Anonymous], ARZNEIMITTEL FORSCHU
[2]  
[Anonymous], KHIM PHARMZH
[3]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[4]  
Dimoglo AS, 1997, CURR MED CHEM, V4, P23
[5]   Structure-ambergris odour relationship investigation in a mixed series of decalin and non-decalin compounds: the electronic-topological approach [J].
Dimoglo, AS ;
Vlad, PF ;
Shvets, NM ;
Coltsa, MN .
NEW JOURNAL OF CHEMISTRY, 2001, 25 (02) :283-288
[6]  
Dimoglo AS, 2001, QUANT STRUCT-ACT REL, V20, P31, DOI 10.1002/1521-3838(200105)20:1<31::AID-QSAR31>3.0.CO
[7]  
2-S
[8]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes [J].
Dorn, CP ;
Finke, PE ;
Oates, B ;
Budhu, RJ ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Daugherty, BL ;
Gould, SL ;
DeMartino, JA ;
Siciliano, SJ ;
Carella, A ;
Carver, G ;
Holmes, K ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Schleif, WA ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) :259-264
[9]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 3:: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)4-[4-(substituted)piperidin-1yl]butanes [J].
Finke, PE ;
Meurer, LC ;
Oates, B ;
Shah, SK ;
Loebach, JL ;
Mills, SG ;
MacCoss, M ;
Castonguay, L ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) :2469-2473
[10]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes [J].
Finke, PE ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA ;
Carella, A ;
Carver, G ;
Holmes, K ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Schleif, WA ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) :2475-2479